Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis

Autor: Kf, Laserson, Le, Thorpe, Leimane V, Weyer K, Cd, Mitnick, Riekstina V, Zarovska E, Ml, Rich, Hamish Fraser, Alarcón E, Jp, Cegielski, Grzemska M, Gupta R, Espinal M

Publikováno v: Europe PubMed Central

Globally it is estimated that 273000 new cases of multidrug-resistant tuberculosis (MDR-TB, resistance to isoniazid and rifampicin) occurred in 2000. To address MDR-TB management in the context of the DOTS strategy, the World Health Organization and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6e0b5c68160707e8f3fb911e37cba3c6
https://pubmed.ncbi.nlm.nih.gov/15971391

Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.

Autor: Kho S; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA., Seung KJ; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.; Partners in Health, 800 Boylston Street Suite 300, Boston, MA, USA., Huerga H; Epicentre, 14-34 Avenue Jean Jaurès, Paris, France., Bastard M; Epicentre, 14-34 Avenue Jean Jaurès, Paris, France., Khan PY; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.; Interactive Research and Development Global, Singapore, Singapore., Mitnick CD; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.; Partners in Health, 800 Boylston Street Suite 300, Boston, MA, USA.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Rich ML; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.; Partners in Health, 800 Boylston Street Suite 300, Boston, MA, USA., Islam S; Interactive Research and Development, Dhaka, Bangladesh., Zhizhilashvili D; Médecins sans Frontières, Tbilisi, Georgia., Yeghiazaryan L; National Center for Pulmonology, Yerevan, Armenia., Nikolenko EN; Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus., Zarli K; Médecins sans Frontières, Yangon, Myanmar., Adnan S; Indus Hospital and Health Network, Karachi, Pakistan., Salahuddin N; Indus Hospital and Health Network, Karachi, Pakistan., Ahmed S; Interactive Research and Development, Karachi, Pakistan., Vargas ZHR; Maria Auxiliadora Hospital, San Juan de Miraflores, Peru., Bekele A; Department of Internal Medicine, Tikur Anbessa Specialized Hospital and Addis Ababa University, College of Health Sciences, Addis Ababa, Ethiopia., Shaimerdenova A; Karaganda Regional Center of Phthisiopulmonology, Karaganda, Kazakhstan., Tamirat M; Partners in Health, Lesotho, Maseru, Lesotho., Gelin A; Zanmi Lasante, Port-au-Prince, Haiti., Vilbrun SC; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Hewison C; Medical Department, Médecins sans Frontières, Paris, France., Khan U; Interactive Research and Development Global, Singapore, Singapore., Franke M; Partners in Health, 800 Boylston Street Suite 300, Boston, MA, USA. molly_franke@hms.harvard.edu.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA. molly_franke@hms.harvard.edu.

Publikováno v: Nature communications [Nat Commun] 2024 May 09; Vol. 15 (1), pp. 3927. Date of Electronic Publication: 2024 May 09.

Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.

Autor: Lotia Farrukh I; Interactive Research and Development Pakistan, Karachi, Pakistan., Lachenal N; Pharmacovigilance Unit, Médecins Sans Frontières, Geneva, Switzerland., Adenov MM; National Scientific Center of Phthisiopulmonology, Ministry of Health, Republic of Kazakhstan, Almaty, Kazakhstan., Ahmed S; Interactive Research and Development Pakistan, Karachi, Pakistan., Algozhin Y; Partners In Health, Almaty, Kazakhstan., Coutisson S; Pharmacovigilance Unit, Médecins Sans Frontières, Geneva, Switzerland., Garavito ES; Centro de Investigación de Enfermedades Neumológicas, Hospital Nacional Sergio Bernale, Lima, Peru., Hewison C; Medical Department, Médecins Sans Frontières, Paris, France., Holtzman D; Partners In Health, Maseru, Lesotho., Huerga H; Field Epidemiology Department, Epicentre, Paris, France., Janmohamed A; Interactive Research and Development Pakistan, Karachi, Pakistan., Khan PY; Interactive Research and Development Pakistan, Karachi, Pakistan.; London School of Hygiene & Tropical Medicine, London, United Kingdom., Jacques GL; Zanmi Lasante, Cange, Haiti., Lomtadze N; Surveillance and Strategic Planning, Ministry of Health, Tbilisi, Georgia., Melikyan N; Field Epidemiology Department, Epicentre, Yerevan, Armenia., Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Partners In Health, Boston, Massachusetts, USA., Mussabekova G; National Scientific Center of Phthisiopulmonology, Ministry of Health, Republic of Kazakhstan, Almaty, Kazakhstan., Osso E; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA., Perea S; Socios En Salud Sucursal Peru, Lima, Peru., Putri FA; Interactive Research and Development Global, Jakarta, Indonesia., Rashidov M; Partners In Health, Almaty, Kazakhstan., Rich ML; Partners In Health, Boston, Massachusetts, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA., Sakhabutdinova Y; Partners In Health, Almaty, Kazakhstan., Seung KJ; Partners In Health, Boston, Massachusetts, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA., Stambekova A; Partners In Health, Almaty, Kazakhstan., Vásquez DV; Centro de Investigación, Hospital Nacional Hipólito Unanue, Lima, Peru., Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA., Khan U; Interactive Research and Development Pakistan, Karachi, Pakistan.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jan 25; Vol. 78 (1), pp. 144-148.

Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.

Autor: Patil SB; Indian Council of Medical Research (ICMR) - National AIDS Research Institute, Pune, India., Tamirat M; Partners In Health, Maseru, Lesotho., Khazhidinov K; Partners In Health, Astana, Kazakhstan., Ardizzoni E; Institute of Tropical Medicine (ITM), Antwerp, Belgium., Atger M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Austin A; UCSF Center for Tuberculosis, University of California, , San Francisco, San Francisco, CA, USA., Baudin E; Epicentre, Paris, France., Bekhit M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Bektasov S; National TB Center, Almaty, Kazakhstan., Berikova E; Partners In Health, Astana, Kazakhstan.; National Scientific Center of Phthisiopulmonology, Almaty, Kazakhstan., Bonnet M; Université de Montpellier, IRD, INSERM, Montpellier, TransVIHMI, France., Caboclo R; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Chaudhry M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Chavan V; Médecins Sans Frontières, Mumbai, India., Cloez S; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Coit J; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Coutisson S; Médecins Sans Frontières, Geneva, Switzerland., Dakenova Z; City Center of Phthisiopulmonology, Astana, Kazakhstan., De Jong BC; Institute of Tropical Medicine (ITM), Antwerp, Belgium., Delifer C; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Demaisons S; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Do JM; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Dos Santos Tozzi D; Incyte, Morges, Switzerland., Ducher V; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Ferlazzo G; Médecins Sans Frontières, Geneva, Switzerland., Gouillou M; Epicentre, Paris, France., Khan U; Interactive Research and Development (IRD) Global, Singapore, Singapore., Kunda M; Partners In Health, Maseru, Lesotho., Lachenal N; Médecins Sans Frontières, Geneva, Switzerland., LaHood AN; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Lecca L; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.; Socios En Salud-Sucursal Peru, Lima, Peru., Mazmanian M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France.; Assistance Publique Hôpitaux de Paris (APHP), Unité de Recherche Clinique, Hôpital Pitié-Salpêtrière, Paris, France.; Santé Arménie French-Armenian Research Center, Yerevan, Armenia., McIlleron H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Moreau M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Moschioni M; Medicines Patent Pool, Geneva, Switzerland., Nahid P; UCSF Center for Tuberculosis, University of California, , San Francisco, San Francisco, CA, USA., Osso E; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Oyewusi L; Partners In Health, Maseru, Lesotho., Panda S; Indian Council of Medical Research Headquarters, New Delhi, India.; Indian Journal of Medical Research, New Delhi, India., Pâquet A; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Thuong Huu P; Hanoi Lung Hospital, Hanoi, Vietnam., Pichon L; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Rich ML; Partners In Health, Boston, MA, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA., Rupasinghe P; Institute of Tropical Medicine (ITM), Antwerp, Belgium., Salahuddin N; Indus Hospital & Health Network, Karachi, Pakistan., Sanchez Garavito E; Hospital Nacional Sergio E. Bernales, Lima, Peru., Seung KJ; Partners In Health, Boston, MA, USA., Velásquez GE; UCSF Center for Tuberculosis, University of California, , San Francisco, San Francisco, CA, USA.; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Vallet M; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Varaine F; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France., Yuya-Septoh FJ; Epicentre, Paris, France., Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.; Partners In Health, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Guglielmetti L; Medical Department, Médecins Sans Frontières, 14-34 Avenue Jean Jaurès, 75019, Paris, France. Lorenzo.GUGLIELMETTI@paris.msf.org.; Sorbonne Université, INSERM, U1135, Centre d'Immunologie Et Des Maladies Infectieuses, Paris, France. Lorenzo.GUGLIELMETTI@paris.msf.org.; Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris, France. Lorenzo.GUGLIELMETTI@paris.msf.org.

Publikováno v: Trials [Trials] 2023 Nov 30; Vol. 24 (1), pp. 773. Date of Electronic Publication: 2023 Nov 30.

Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications.

Autor: Rich ML; Division of Global Health Equity, Brigham and Women´s Hospital, Boston, MA, Partners In Health, Boston, MA, USA., Khan U; Interactive Research & Development Global, Singapore, Singapore., Zeng C; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., LaHood A; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Atwood S; Division of Global Health Equity, Brigham and Women´s Hospital, Boston, MA., Bastard M; Epicentre, Paris, France., Burhan E; Persahabatan General Hospital, Jakarta, Indonesia., Danielyan N; Médecins Sans Frontières (MSF), Tbilisi, Georgia., Dzhazibekova PM; National Science Center, Almaty, Republic of Kazakhstan., Gadissa D; Partners In Health (PIH), Addis Ababa, Ethiopia., Ghafoor A; National Tuberculosis Programme (NTP), Ministry of National Health, Islamabad, Pakistan., Hewison C; MSF, Paris, France., Islam MS; Interactive Research & Development, Dhaka, Bangladesh., Kazmi E; Directorate General Health Services, Centers for Disease Control and Prevention, Sindh, Pakistan., Khan PY; Partners In Health, Boston, MA, USA, Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK., Lecca L; Socios En Salud Sucursal, Lima, Peru., Maama LB; PIH, Maseru, Lesotho, NTP, Maseru, Lesotho., Melikyan N; Epicentre, Paris, France, MSF, Yerevan, Armenia., Naing YY; MSF, Yangon, Myanmar., Philippe K; Zanmi Lasante, Cange, Haiti., Saki NA; World Health Organization, Country Office, Dhaka, Bangladesh., Seung KJ; Division of Global Health Equity, Brigham and Women´s Hospital, Boston, MA, Partners In Health, Boston, MA, USA., Skrahina A; MSF, Minsk, Belarus., Tefera GB; Partners In Health (PIH), Addis Ababa, Ethiopia., Varaine F; MSF, Paris, France., Vilbrun SC; GHESKIO Institute of Infectious Diseases and Reproductive Health, NTP, Port-au-Prince, Haiti., Võ L; Friends for International TB Relief, Ho Chi Minh City, Vietnam., Mitnick CD; Division of Global Health Equity, Brigham and Women´s Hospital, Boston, MA, Partners In Health, Boston, MA, USA, Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Huerga H; Epicentre, Paris, France.

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2023 Jun 01; Vol. 27 (6), pp. 451-457.